Surfacide is one of a handful of med-tech startups that Scott Wilson at MINIMAL began investing in, partnering with and designing for. He and his small team are helping an industry veteran design, engineer, develop and commercialize a smart, UV-C light-based disinfection system that will eradicate infectious bacteria at a cellular level. Operated predominantly by environmental service employees with hSD education, the system control is designed around a simple touch interface via tablet controller. Connected to a central cloud-based database, the information collected will help track and further reduce the chance of infection. The Surfacide helios System solves existing UV-C technology challenges by eliminating shadows in patient environments and reducing proximity to high-touch surfaces. By implementing multiple light emitters in patient environments, the helios System overcomes the obstacles of using single emitter UV-C light systems. The system eradicates multi-drug resistant organisms including C. Diff, MRSA, VRE, CRE and Acinetobacter. The Surfacide system implements multiple emitters into the patient environment that allows it to clean all areas of the patient room, including the bathroom.